The FY2024 ICD-10-CM guidelines were released Wednesday, July 5 and include updated instructions for how to code for screening for COVID-19.
 
The guidelines take effect Oct. 1, along with the finalized FY2024 code set.
 
Guidelines for screening for COVID-19 can be found at I.C.1.g.1.f and advise:
  • For screening for COVID-19, including preoperative testing, assign code Z11.52 (Encounter for screening for COVID-19).
A change to Myocardial Infarction with Coronary Microvascular Dysfunction is also included at I.C.9.e.6 to state:
  • Coronary microvascular dysfunction (CMD) is a condition that impacts the microvasculature by restricting microvascular flow and increasing microvascular resistance. Code I21.B, Myocardial infarction with coronary microvascular dysfunction, is assigned for myocardial infarction with coronary microvascular disease, myocardial infarction with coronary microvascular dysfunction, and myocardial infarction with non-obstructive coronary arteries (MINOCA) with microvascular disease
For more detailed coverage, see future issues of DecisionHealth newsletters.
 
To view the full guidelines, visit https://tinyurl.com/hwbxx5c4.